Global Respiratory Disease Vaccine Market Size study & Forecast, by Type (Viral Vaccine, Bacterial Vaccine, Combination Vaccine) by Age Group (Pediatric, Adult), by Infection (COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Pneumonia, Others), by Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, Others) and Regional Analysis, 2023-2030
Global Respiratory Disease Vaccine Market is valued approximately USD 92.23 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 1.21% over the forecast period 2023-2030. Respiratory diseases affect the respiratory system, which includes the organs involved in breathing. The respiratory system is responsible for the intake of oxygen and the elimination of carbon dioxide from the body. Various conditions can disrupt the normal functioning of the respiratory system, leading to respiratory diseases. The Respiratory Disease Vaccine market is expanding because of factors such as the rising prevalence of respiratory disorders and increasing research and development activities for vaccine development.
The rising prevalence of various respiratory diseases such as Asthma, Pneumonia, Tuberculosis, and more is driving the market growth. For instance, the World Health Organization's (WHO) Global Tuberculosis Report 2021 states that in October 2021, most tuberculosis cases were discovered in South-East Asia (43%), Africa (25%), and the Western Pacific (18%), while fewer cases were discovered in the Eastern Mediterranean (8.3%), and Europe (2.3%). Additionally, according to statistics released by the World Health Organization (WHO), around 10 million individuals worldwide contracted tuberculosis in 2020, and roughly 1.5 million people died as a result of the disease in October 2021. Moreover, according to Statista in the year 2015, the Number of cases of asthma in senior citizens across India stood at 9 million which increased to 10.7 million in the year 2020, and it is projected to reach 25.4 million by the year 2050. Thus, the rising prevalence of respiratory diseases across the growth is driving the market growth. In addition, increasing government support for vaccine development activities and a rising number of awareness programs is creating a lucrative opportunity to market growth. However, the high cost involved with research and development of respiratory disease vaccines stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Respiratory Disease Vaccine Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the availability of advanced healthcare technologies for vaccine development, rising number of research and development programs, rising investment by public and private companies, and rising healthcare expenditure. Whereas, Asia Pacific is projected to register significant growth owing to factors such as the rising prevalence of targeted diseases, rising healthcare expenditure, and rising government initiatives to promote vaccine development in the region.
Major market player included in this report are:
GSK plc.
Johnson & Johnson Services, Inc.
Pfizer Inc.
Sanofi- Aventis
Serum Institute of India Pvt. Ltd.
Sinovac Biotech Ltd
Bavarian Nordic A/S
Merck & Co., Inc.
AstraZeneca plc
Emergent BioSolutions Inc
Recent Developments in the Market:
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Viral Vaccine
Bacterial Vaccine
Combination Vaccine
By Age Group:
Pediatric
Adult
By Infection:
COVID-19
Influenza
Respiratory Syncytial Virus (RSV)
Pneumonia
Others
By Distribution Channel:
Hospital & Retail Pharmacies
Government Suppliers
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
The rising prevalence of various respiratory diseases such as Asthma, Pneumonia, Tuberculosis, and more is driving the market growth. For instance, the World Health Organization's (WHO) Global Tuberculosis Report 2021 states that in October 2021, most tuberculosis cases were discovered in South-East Asia (43%), Africa (25%), and the Western Pacific (18%), while fewer cases were discovered in the Eastern Mediterranean (8.3%), and Europe (2.3%). Additionally, according to statistics released by the World Health Organization (WHO), around 10 million individuals worldwide contracted tuberculosis in 2020, and roughly 1.5 million people died as a result of the disease in October 2021. Moreover, according to Statista in the year 2015, the Number of cases of asthma in senior citizens across India stood at 9 million which increased to 10.7 million in the year 2020, and it is projected to reach 25.4 million by the year 2050. Thus, the rising prevalence of respiratory diseases across the growth is driving the market growth. In addition, increasing government support for vaccine development activities and a rising number of awareness programs is creating a lucrative opportunity to market growth. However, the high cost involved with research and development of respiratory disease vaccines stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Respiratory Disease Vaccine Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the availability of advanced healthcare technologies for vaccine development, rising number of research and development programs, rising investment by public and private companies, and rising healthcare expenditure. Whereas, Asia Pacific is projected to register significant growth owing to factors such as the rising prevalence of targeted diseases, rising healthcare expenditure, and rising government initiatives to promote vaccine development in the region.
Major market player included in this report are:
GSK plc.
Johnson & Johnson Services, Inc.
Pfizer Inc.
Sanofi- Aventis
Serum Institute of India Pvt. Ltd.
Sinovac Biotech Ltd
Bavarian Nordic A/S
Merck & Co., Inc.
AstraZeneca plc
Emergent BioSolutions Inc
Recent Developments in the Market:
- In February 2022, Moderna, Inc. declared plans to expand its footprint in the region by creating new companies in Taiwan, Malaysia, Singapore, Hong Kong, and Taiwan in order to scale up the manufacture and distribution of mRNA and the COVID-9 vaccine.
- In May 2023, The US Food and Drug Administration (FDA) approved Arexvy (the respiratory syncytial virus vaccine, adjuvanted) for use in people 60 years of age and older to prevent lower respiratory tract disease (LRTD) brought on by the respiratory syncytial virus (RSV).
- Historical Data – 2020 - 2021
- Base Year for Estimation – 2022
- Forecast period - 2023-2030
- Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
- Segments Covered – Type, Age Group, Infection, Distribution Channel, Region
- Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
- Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Viral Vaccine
Bacterial Vaccine
Combination Vaccine
By Age Group:
Pediatric
Adult
By Infection:
COVID-19
Influenza
Respiratory Syncytial Virus (RSV)
Pneumonia
Others
By Distribution Channel:
Hospital & Retail Pharmacies
Government Suppliers
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Respiratory Disease Vaccine Market, by Region, 2020-2030 (USD Billion)
1.2.2. Respiratory Disease Vaccine Market, by Type, 2020-2030 (USD Billion)
1.2.3. Respiratory Disease Vaccine Market, by Age Group, 2020-2030 (USD Billion)
1.2.4. Respiratory Disease Vaccine Market, by Infection, 2020-2030 (USD Billion)
1.2.5. Respiratory Disease Vaccine Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL RESPIRATORY DISEASE VACCINE MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL RESPIRATORY DISEASE VACCINE MARKET DYNAMICS
3.1. Respiratory Disease Vaccine Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Rising prevalence of respiratory disorders
3.1.1.2. Increasing research and development activities for vaccine development
3.1.2. Market Challenges
3.1.2.1. High initial cost of respiratory disease vaccine development
3.1.3. Market Opportunities
3.1.3.1. Increasing government support for the vaccine development activities
3.1.3.2. Rising number of disease awareness programs
CHAPTER 4. GLOBAL RESPIRATORY DISEASE VACCINE MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL RESPIRATORY DISEASE VACCINE MARKET, BY TYPE
5.1. Market Snapshot
5.2. Global Respiratory Disease Vaccine Market by Type, Performance - Potential Analysis
5.3. Global Respiratory Disease Vaccine Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
5.4. Respiratory Disease Vaccine Market, Sub Segment Analysis
5.4.1. Viral Vaccine
5.4.2. Bacterial Vaccine
5.4.3. Combination Vaccine
CHAPTER 6. GLOBAL RESPIRATORY DISEASE VACCINE MARKET, BY AGE GROUP
6.1. Market Snapshot
6.2. Global Respiratory Disease Vaccine Market by Age Group, Performance - Potential Analysis
6.3. Global Respiratory Disease Vaccine Market Estimates & Forecasts by Age Group 2020-2030 (USD Billion)
6.4. Respiratory Disease Vaccine Market, Sub Segment Analysis
6.4.1. Pediatric
6.4.2. Adult
CHAPTER 7. GLOBAL RESPIRATORY DISEASE VACCINE MARKET, BY INFECTION
7.1. Market Snapshot
7.2. Global Respiratory Disease Vaccine Market by Infection, Performance - Potential Analysis
7.3. Global Respiratory Disease Vaccine Market Estimates & Forecasts by Infection 2020-2030 (USD Billion)
7.4. Respiratory Disease Vaccine Market, Sub Segment Analysis
7.4.1. COVID-19
7.4.2. Influenza
7.4.3. Respiratory Syncytial Virus (RSV)
7.4.4. Pneumonia
7.4.5. Others
CHAPTER 8. GLOBAL RESPIRATORY DISEASE VACCINE MARKET, BY DISTRIBUTION CHANNEL
8.1. Market Snapshot
8.2. Global Respiratory Disease Vaccine Market by Distribution Channel, Performance - Potential Analysis
8.3. Global Respiratory Disease Vaccine Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
8.4. Respiratory Disease Vaccine Market, Sub Segment Analysis
8.4.1. Hospital & Retail Pharmacies
8.4.2. Government Suppliers
8.4.3. Others
CHAPTER 9. GLOBAL RESPIRATORY DISEASE VACCINE MARKET, REGIONAL ANALYSIS
9.1. Top Leading Countries
9.2. Top Emerging Countries
9.3. Respiratory Disease Vaccine Market, Regional Market Snapshot
9.4. North America Respiratory Disease Vaccine Market
9.4.1. U.S. Respiratory Disease Vaccine Market
9.4.1.1. Type breakdown estimates & forecasts, 2020-2030
9.4.1.2. Age Group breakdown estimates & forecasts, 2020-2030
9.4.1.3. Infection breakdown estimates & forecasts, 2020-2030
9.4.1.4. Distribution Channel breakdown estimates & forecasts, 2020-2030
9.4.2. Canada Respiratory Disease Vaccine Market
9.5. Europe Respiratory Disease Vaccine Market Snapshot
9.5.1. U.K. Respiratory Disease Vaccine Market
9.5.2. Germany Respiratory Disease Vaccine Market
9.5.3. France Respiratory Disease Vaccine Market
9.5.4. Spain Respiratory Disease Vaccine Market
9.5.5. Italy Respiratory Disease Vaccine Market
9.5.6. Rest of Europe Respiratory Disease Vaccine Market
9.6. Asia-Pacific Respiratory Disease Vaccine Market Snapshot
9.6.1. China Respiratory Disease Vaccine Market
9.6.2. India Respiratory Disease Vaccine Market
9.6.3. Japan Respiratory Disease Vaccine Market
9.6.4. Australia Respiratory Disease Vaccine Market
9.6.5. South Korea Respiratory Disease Vaccine Market
9.6.6. Rest of Asia Pacific Respiratory Disease Vaccine Market
9.7. Latin America Respiratory Disease Vaccine Market Snapshot
9.7.1. Brazil Respiratory Disease Vaccine Market
9.7.2. Mexico Respiratory Disease Vaccine Market
9.8. Middle East & Africa Respiratory Disease Vaccine Market
9.8.1. Saudi Arabia Respiratory Disease Vaccine Market
9.8.2. South Africa Respiratory Disease Vaccine Market
9.8.3. Rest of Middle East & Africa Respiratory Disease Vaccine Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Key Company SWOT Analysis
10.1.1. Company
10.1.2. Company
10.1.3. Company
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. GSK plc.
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Recent Developments
10.3.2. Johnson & Johnson Services, Inc.
10.3.3. Pfizer Inc.
10.3.4. Sanofi- Aventis
10.3.5. Serum Institute of India Pvt. Ltd.
10.3.6. Sinovac Biotech Ltd
10.3.7. Bavarian Nordic A/S
10.3.8. Merck & Co., Inc.
10.3.9. AstraZeneca plc
10.3.10. Emergent BioSolutions Inc
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Respiratory Disease Vaccine Market, by Region, 2020-2030 (USD Billion)
1.2.2. Respiratory Disease Vaccine Market, by Type, 2020-2030 (USD Billion)
1.2.3. Respiratory Disease Vaccine Market, by Age Group, 2020-2030 (USD Billion)
1.2.4. Respiratory Disease Vaccine Market, by Infection, 2020-2030 (USD Billion)
1.2.5. Respiratory Disease Vaccine Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL RESPIRATORY DISEASE VACCINE MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL RESPIRATORY DISEASE VACCINE MARKET DYNAMICS
3.1. Respiratory Disease Vaccine Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Rising prevalence of respiratory disorders
3.1.1.2. Increasing research and development activities for vaccine development
3.1.2. Market Challenges
3.1.2.1. High initial cost of respiratory disease vaccine development
3.1.3. Market Opportunities
3.1.3.1. Increasing government support for the vaccine development activities
3.1.3.2. Rising number of disease awareness programs
CHAPTER 4. GLOBAL RESPIRATORY DISEASE VACCINE MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL RESPIRATORY DISEASE VACCINE MARKET, BY TYPE
5.1. Market Snapshot
5.2. Global Respiratory Disease Vaccine Market by Type, Performance - Potential Analysis
5.3. Global Respiratory Disease Vaccine Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
5.4. Respiratory Disease Vaccine Market, Sub Segment Analysis
5.4.1. Viral Vaccine
5.4.2. Bacterial Vaccine
5.4.3. Combination Vaccine
CHAPTER 6. GLOBAL RESPIRATORY DISEASE VACCINE MARKET, BY AGE GROUP
6.1. Market Snapshot
6.2. Global Respiratory Disease Vaccine Market by Age Group, Performance - Potential Analysis
6.3. Global Respiratory Disease Vaccine Market Estimates & Forecasts by Age Group 2020-2030 (USD Billion)
6.4. Respiratory Disease Vaccine Market, Sub Segment Analysis
6.4.1. Pediatric
6.4.2. Adult
CHAPTER 7. GLOBAL RESPIRATORY DISEASE VACCINE MARKET, BY INFECTION
7.1. Market Snapshot
7.2. Global Respiratory Disease Vaccine Market by Infection, Performance - Potential Analysis
7.3. Global Respiratory Disease Vaccine Market Estimates & Forecasts by Infection 2020-2030 (USD Billion)
7.4. Respiratory Disease Vaccine Market, Sub Segment Analysis
7.4.1. COVID-19
7.4.2. Influenza
7.4.3. Respiratory Syncytial Virus (RSV)
7.4.4. Pneumonia
7.4.5. Others
CHAPTER 8. GLOBAL RESPIRATORY DISEASE VACCINE MARKET, BY DISTRIBUTION CHANNEL
8.1. Market Snapshot
8.2. Global Respiratory Disease Vaccine Market by Distribution Channel, Performance - Potential Analysis
8.3. Global Respiratory Disease Vaccine Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
8.4. Respiratory Disease Vaccine Market, Sub Segment Analysis
8.4.1. Hospital & Retail Pharmacies
8.4.2. Government Suppliers
8.4.3. Others
CHAPTER 9. GLOBAL RESPIRATORY DISEASE VACCINE MARKET, REGIONAL ANALYSIS
9.1. Top Leading Countries
9.2. Top Emerging Countries
9.3. Respiratory Disease Vaccine Market, Regional Market Snapshot
9.4. North America Respiratory Disease Vaccine Market
9.4.1. U.S. Respiratory Disease Vaccine Market
9.4.1.1. Type breakdown estimates & forecasts, 2020-2030
9.4.1.2. Age Group breakdown estimates & forecasts, 2020-2030
9.4.1.3. Infection breakdown estimates & forecasts, 2020-2030
9.4.1.4. Distribution Channel breakdown estimates & forecasts, 2020-2030
9.4.2. Canada Respiratory Disease Vaccine Market
9.5. Europe Respiratory Disease Vaccine Market Snapshot
9.5.1. U.K. Respiratory Disease Vaccine Market
9.5.2. Germany Respiratory Disease Vaccine Market
9.5.3. France Respiratory Disease Vaccine Market
9.5.4. Spain Respiratory Disease Vaccine Market
9.5.5. Italy Respiratory Disease Vaccine Market
9.5.6. Rest of Europe Respiratory Disease Vaccine Market
9.6. Asia-Pacific Respiratory Disease Vaccine Market Snapshot
9.6.1. China Respiratory Disease Vaccine Market
9.6.2. India Respiratory Disease Vaccine Market
9.6.3. Japan Respiratory Disease Vaccine Market
9.6.4. Australia Respiratory Disease Vaccine Market
9.6.5. South Korea Respiratory Disease Vaccine Market
9.6.6. Rest of Asia Pacific Respiratory Disease Vaccine Market
9.7. Latin America Respiratory Disease Vaccine Market Snapshot
9.7.1. Brazil Respiratory Disease Vaccine Market
9.7.2. Mexico Respiratory Disease Vaccine Market
9.8. Middle East & Africa Respiratory Disease Vaccine Market
9.8.1. Saudi Arabia Respiratory Disease Vaccine Market
9.8.2. South Africa Respiratory Disease Vaccine Market
9.8.3. Rest of Middle East & Africa Respiratory Disease Vaccine Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Key Company SWOT Analysis
10.1.1. Company
10.1.2. Company
10.1.3. Company
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. GSK plc.
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Recent Developments
10.3.2. Johnson & Johnson Services, Inc.
10.3.3. Pfizer Inc.
10.3.4. Sanofi- Aventis
10.3.5. Serum Institute of India Pvt. Ltd.
10.3.6. Sinovac Biotech Ltd
10.3.7. Bavarian Nordic A/S
10.3.8. Merck & Co., Inc.
10.3.9. AstraZeneca plc
10.3.10. Emergent BioSolutions Inc
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Respiratory Disease Vaccine Market, report scope
TABLE 2. Global Respiratory Disease Vaccine Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Respiratory Disease Vaccine Market estimates & forecasts by Type 2020-2030 (USD Billion)
TABLE 4. Global Respiratory Disease Vaccine Market estimates & forecasts by Age Group 2020-2030 (USD Billion)
TABLE 5. Global Respiratory Disease Vaccine Market estimates & forecasts by Infection 2020-2030 (USD Billion)
TABLE 6. Global Respiratory Disease Vaccine Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
TABLE 7. Global Respiratory Disease Vaccine Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Respiratory Disease Vaccine Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Respiratory Disease Vaccine Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Respiratory Disease Vaccine Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Respiratory Disease Vaccine Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Respiratory Disease Vaccine Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Respiratory Disease Vaccine Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Respiratory Disease Vaccine Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Respiratory Disease Vaccine Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. Global Respiratory Disease Vaccine Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 18. U.S. Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. U.S. Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 21. Canada Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. Canada Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 24. UK Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. UK Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 27. Germany Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. Germany Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 30. France Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. France Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 33. Italy Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Italy Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 36. Spain Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. Spain Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 39. RoE Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. RoE Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 42. China Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. China Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 45. India Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. India Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 48. Japan Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. Japan Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 51. South Korea Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. South Korea Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 54. Australia Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. Australia Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 57. RoAPAC Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. RoAPAC Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 60. Brazil Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Brazil Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 63. Mexico Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. Mexico Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 66. RoLA Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. RoLA Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. Saudi Arabia Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 69. South Africa Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. RoMEA Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 71. List of secondary sources, used in the study of global Respiratory Disease Vaccine Market
TABLE 72. List of primary sources, used in the study of global Respiratory Disease Vaccine Market
TABLE 73. Years considered for the study
TABLE 74. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Respiratory Disease Vaccine Market, report scope
TABLE 2. Global Respiratory Disease Vaccine Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Respiratory Disease Vaccine Market estimates & forecasts by Type 2020-2030 (USD Billion)
TABLE 4. Global Respiratory Disease Vaccine Market estimates & forecasts by Age Group 2020-2030 (USD Billion)
TABLE 5. Global Respiratory Disease Vaccine Market estimates & forecasts by Infection 2020-2030 (USD Billion)
TABLE 6. Global Respiratory Disease Vaccine Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
TABLE 7. Global Respiratory Disease Vaccine Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Respiratory Disease Vaccine Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Respiratory Disease Vaccine Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Respiratory Disease Vaccine Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Respiratory Disease Vaccine Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Respiratory Disease Vaccine Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Respiratory Disease Vaccine Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Respiratory Disease Vaccine Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Respiratory Disease Vaccine Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. Global Respiratory Disease Vaccine Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 18. U.S. Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. U.S. Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 21. Canada Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. Canada Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 24. UK Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. UK Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 27. Germany Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. Germany Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 30. France Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. France Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 33. Italy Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Italy Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 36. Spain Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. Spain Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 39. RoE Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. RoE Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 42. China Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. China Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 45. India Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. India Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 48. Japan Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. Japan Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 51. South Korea Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. South Korea Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 54. Australia Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. Australia Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 57. RoAPAC Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. RoAPAC Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 60. Brazil Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Brazil Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 63. Mexico Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. Mexico Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 66. RoLA Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. RoLA Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. Saudi Arabia Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 69. South Africa Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. RoMEA Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 71. List of secondary sources, used in the study of global Respiratory Disease Vaccine Market
TABLE 72. List of primary sources, used in the study of global Respiratory Disease Vaccine Market
TABLE 73. Years considered for the study
TABLE 74. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Respiratory Disease Vaccine Market, research methodology
FIG 2. Global Respiratory Disease Vaccine Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Respiratory Disease Vaccine Market, key trends 2022
FIG 5. Global Respiratory Disease Vaccine Market, growth prospects 2023-2030
FIG 6. Global Respiratory Disease Vaccine Market, porters 5 force model
FIG 7. Global Respiratory Disease Vaccine Market, pest analysis
FIG 8. Global Respiratory Disease Vaccine Market, value chain analysis
FIG 9. Global Respiratory Disease Vaccine Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Respiratory Disease Vaccine Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Respiratory Disease Vaccine Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Respiratory Disease Vaccine Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Respiratory Disease Vaccine Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Respiratory Disease Vaccine Market, regional snapshot 2020 & 2030
FIG 15. North America Respiratory Disease Vaccine Market 2020 & 2030 (USD Billion)
FIG 16. Europe Respiratory Disease Vaccine Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Respiratory Disease Vaccine Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Respiratory Disease Vaccine Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Respiratory Disease Vaccine Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Respiratory Disease Vaccine Market, research methodology
FIG 2. Global Respiratory Disease Vaccine Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Respiratory Disease Vaccine Market, key trends 2022
FIG 5. Global Respiratory Disease Vaccine Market, growth prospects 2023-2030
FIG 6. Global Respiratory Disease Vaccine Market, porters 5 force model
FIG 7. Global Respiratory Disease Vaccine Market, pest analysis
FIG 8. Global Respiratory Disease Vaccine Market, value chain analysis
FIG 9. Global Respiratory Disease Vaccine Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Respiratory Disease Vaccine Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Respiratory Disease Vaccine Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Respiratory Disease Vaccine Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Respiratory Disease Vaccine Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Respiratory Disease Vaccine Market, regional snapshot 2020 & 2030
FIG 15. North America Respiratory Disease Vaccine Market 2020 & 2030 (USD Billion)
FIG 16. Europe Respiratory Disease Vaccine Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Respiratory Disease Vaccine Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Respiratory Disease Vaccine Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Respiratory Disease Vaccine Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
